New research from the University of Liverpool, published in the journal Brain, has highlighted the potential reasons why many patients with severe epilepsy still continue to experience seizures even ...
mFOLFOX6 + bevacizumab + PD-1 monoclonal antibody vs. mFOLFOX6 in locally advanced pMMR/MSS CRC: A multicenter, randomized controlled phase III study (BASKETIII). This is an ASCO Meeting Abstract from ...
Epilepsy is one of the most common neurological disorders, affecting 3.4 million Americans or 1 in 26 over a lifetime. The hallmark of epilepsy is seizures caused by abnormal bursts of electrical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results